Fig. 6: Prognosis of pathological stage I non-small cell lung cancer with adjuvant therapy and without adjuvant therapy for low-risk and high-risk patients in the validation set and external cohort.
From: PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer
Survival comparisons between with adjuvant therapy versus without adjuvant therapy in (A) and (B) low-risk and (C) and (D) high-risk patients. n = 1182 biologically independent samples were examined. Survival data were compared by the log-rank test. Source data are provided as a Source Data file. POAT, postoperative adjuvant therapy; OS, overall survival; RFS, recurrence-free survival.
